First patient dosed in phase II study of OTX-DED for short-term treatment of dry eye disease March 2, 2021
FDA issues complete response letter for oral paclitaxel plus encequidar in metastatic breast cancer March 2, 2021
FDA agrees to advance VERU-111 into phase III study in COVID-19 patients at high risk for ARDS March 2, 2021
RSS